Particulars |
|
|
|
Company Name
| Marksans Pharma Ltd
| Year End
| 202503
|
Full Year |
Equity (₹ Cr.) |
45.32 |
B.V. (₹) |
30.50 |
Sales(₹ Cr.) |
1,174.37 |
NP (₹ Cr.) |
188.27 |
NP Var (%) |
41.00 |
Div% |
80.00 |
CPS(₹) |
4.80 |
EPS (₹) |
4.20 |
Traded Value(₹ Lakhs) |
298.08 |
52 Week High |
359.00 |
52 Week Low |
130.00 |
Price BSE |
260.00 |
Price NSE |
260.00 |
Market Capital (₹ Cr.) |
11,798.12 |
P/C Ratio |
54.10 |
P/E Ratio |
62.60 |
Price Vs.BV |
8.52 |
|
Latest Quarter |
Year End |
202503 |
Sales (₹ Cr.) |
299.36 |
NP(₹ Cr.) |
37.59 |
NP Var % |
14.00 |
Trailing Twelve Months |
Year End |
202503 |
Sales |
1,029.71 |
OPM |
16.45 |
NP |
153.50 |
NP Var (%) |
40.82 |
EPS |
4.15 |
PE |
62.73 |
|
|